Fe3+ loaded mastoparan M - ICG nanoassemblies for synergistic breast cancer therapy via photothermal and chemodynamic therapy-assisted oxidation stress
In vitro and in vivo studies demonstrated enhanced antitumor efficacy with reduced systemic toxicity in Mastoparan M, highlighting the potential of carrier-free nanodrugs for oxidative stress-based breast cancer therapy.